Cargando…

Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo

Micropterus salmoides rhabdovirus (MSRV) is a primary viral pathogen in largemouth bass aquaculture, which leads to tremendous economic losses yearly. Currently, there are no approved drugs for the treatment and control of this virus. Our previous studies screened the herb Magnolia officinalis from...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yingjie, Yang, Fei, Zhang, Gengrong, Yu, Qing, Wang, Gaoxue, Ling, Fei, Liu, Tianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324556/
https://www.ncbi.nlm.nih.gov/pubmed/35891401
http://dx.doi.org/10.3390/v14071421
_version_ 1784756836271915008
author Jin, Yingjie
Yang, Fei
Zhang, Gengrong
Yu, Qing
Wang, Gaoxue
Ling, Fei
Liu, Tianqiang
author_facet Jin, Yingjie
Yang, Fei
Zhang, Gengrong
Yu, Qing
Wang, Gaoxue
Ling, Fei
Liu, Tianqiang
author_sort Jin, Yingjie
collection PubMed
description Micropterus salmoides rhabdovirus (MSRV) is a primary viral pathogen in largemouth bass aquaculture, which leads to tremendous economic losses yearly. Currently, there are no approved drugs for the treatment and control of this virus. Our previous studies screened the herb Magnolia officinalis from many traditional Chinese medicines, and we isolated and identified magnolol as its main active compound against multiple rhabdoviruses, including MSRV. On the basis of the structure–activity relationship and pharmacophore model of magnolol, two new magnolol derivatives, namely, hydrogenated magnolol and 2,2′-dimethoxy-magnolol, were designed and synthesized. Their anti-MSRV activities were systematically investigated both in vitro and in vivo. By comparing the half-maximal inhibitory concentration (IC(50)), it was found that hydrogenated magnolol possessed a higher anti-MSRV activity than magnolol and 2,2′-dimethoxy-magnolol, with an IC(50) of 13.37 μM. Furthermore, hydrogenated magnolol exhibited a protective effect on the grass carp ovary (GCO) cell line by reducing the cytopathic effect induced by MSRV. Further studies revealed that hydrogenated magnolol did not directly impact virions or interfere with MSRV adsorption. It worked within the 6–8 h of the phase of virus replication. In vivo treatment of MSRV infection with magnolol and hydrogenated magnolol showed that they significantly improved the survival rate by 44.6% and 62.7%, respectively, compared to MSRV-infected groups. The viral load measured by the expression of viral glycoprotein in the organs including the liver, spleen, and kidney also significantly decreased when fish were intraperitoneally injected at a dose of 20 mg/kg. Altogether, the structural optimization of magnolol via hydrogenation of the propylene groups increased its anti-MSRV activity both in vitro and in vivo. These results may provide a valuable reference for anti-MSRV drug discovery and development in aquaculture.
format Online
Article
Text
id pubmed-9324556
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93245562022-07-27 Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo Jin, Yingjie Yang, Fei Zhang, Gengrong Yu, Qing Wang, Gaoxue Ling, Fei Liu, Tianqiang Viruses Article Micropterus salmoides rhabdovirus (MSRV) is a primary viral pathogen in largemouth bass aquaculture, which leads to tremendous economic losses yearly. Currently, there are no approved drugs for the treatment and control of this virus. Our previous studies screened the herb Magnolia officinalis from many traditional Chinese medicines, and we isolated and identified magnolol as its main active compound against multiple rhabdoviruses, including MSRV. On the basis of the structure–activity relationship and pharmacophore model of magnolol, two new magnolol derivatives, namely, hydrogenated magnolol and 2,2′-dimethoxy-magnolol, were designed and synthesized. Their anti-MSRV activities were systematically investigated both in vitro and in vivo. By comparing the half-maximal inhibitory concentration (IC(50)), it was found that hydrogenated magnolol possessed a higher anti-MSRV activity than magnolol and 2,2′-dimethoxy-magnolol, with an IC(50) of 13.37 μM. Furthermore, hydrogenated magnolol exhibited a protective effect on the grass carp ovary (GCO) cell line by reducing the cytopathic effect induced by MSRV. Further studies revealed that hydrogenated magnolol did not directly impact virions or interfere with MSRV adsorption. It worked within the 6–8 h of the phase of virus replication. In vivo treatment of MSRV infection with magnolol and hydrogenated magnolol showed that they significantly improved the survival rate by 44.6% and 62.7%, respectively, compared to MSRV-infected groups. The viral load measured by the expression of viral glycoprotein in the organs including the liver, spleen, and kidney also significantly decreased when fish were intraperitoneally injected at a dose of 20 mg/kg. Altogether, the structural optimization of magnolol via hydrogenation of the propylene groups increased its anti-MSRV activity both in vitro and in vivo. These results may provide a valuable reference for anti-MSRV drug discovery and development in aquaculture. MDPI 2022-06-28 /pmc/articles/PMC9324556/ /pubmed/35891401 http://dx.doi.org/10.3390/v14071421 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jin, Yingjie
Yang, Fei
Zhang, Gengrong
Yu, Qing
Wang, Gaoxue
Ling, Fei
Liu, Tianqiang
Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo
title Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo
title_full Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo
title_fullStr Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo
title_full_unstemmed Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo
title_short Synthesized Magnolol Derivatives Improve Anti-Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo
title_sort synthesized magnolol derivatives improve anti-micropterus salmoides rhabdovirus (msrv) activity in vivo
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324556/
https://www.ncbi.nlm.nih.gov/pubmed/35891401
http://dx.doi.org/10.3390/v14071421
work_keys_str_mv AT jinyingjie synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo
AT yangfei synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo
AT zhanggengrong synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo
AT yuqing synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo
AT wanggaoxue synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo
AT lingfei synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo
AT liutianqiang synthesizedmagnololderivativesimproveantimicropterussalmoidesrhabdovirusmsrvactivityinvivo